Published in Am J Kidney Dis on June 01, 2004
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol (2010) 3.82
Atypical hemolytic uremic syndrome. Orphanet J Rare Dis (2011) 3.35
Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med (2009) 3.24
Atypical hemolytic uremic syndrome. Semin Nephrol (2013) 1.56
Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. Kidney Int (2010) 1.56
Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol (2012) 1.36
Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol (2013) 1.32
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol (2013) 1.14
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol (2012) 1.14
Hemolytic uremic syndrome. Semin Immunopathol (2014) 1.12
Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) (2012) 1.10
Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol (2007) 1.09
Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management. Turk J Haematol (2014) 1.05
Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic. PLoS One (2013) 1.04
Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Mol Immunol (2006) 1.03
Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Pediatr Nephrol (2012) 0.97
Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol (2014) 0.94
Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol (2011) 0.92
Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count. Pediatr Nephrol (2012) 0.90
Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger? Pediatr Nephrol (2010) 0.87
Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection. Pediatr Nephrol (2010) 0.86
HUS and TTP in Children. Pediatr Clin North Am (2013) 0.85
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis. Clin Exp Immunol (2007) 0.85
Pathogenesis and prognosis of thrombotic microangiopathy. Clin Exp Nephrol (2007) 0.84
Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A. Microb Pathog (2011) 0.83
Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects. Clin Dev Immunol (2012) 0.83
Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome. Pediatr Nephrol (2014) 0.83
Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infect Dis (2014) 0.82
Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome. Pediatr Nephrol (2010) 0.82
Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan. Eur J Pediatr (2006) 0.81
Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. BMC Infect Dis (2016) 0.80
Management of hemolytic-uremic syndrome in children. Int J Nephrol Renovasc Dis (2014) 0.79
Advances and challenges in the management of complement-mediated thrombotic microangiopathies. Ther Adv Hematol (2015) 0.79
Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab. Hematol Rep (2016) 0.78
Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. Eur J Pediatr (2015) 0.77
Assesment, treatment and prevention of atypical hemolytic uremic syndrome. Int J Prev Med (2013) 0.77
Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange. BMJ Case Rep (2013) 0.77
Atypical hemolytic uremic syndrome and mutation analysis of factor H gene in two Tunisian families. Int J Nephrol Renovasc Dis (2010) 0.76
Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome. J Clin Immunol (2015) 0.76
Diagnosis and management of atypical hemolytic uremic syndrome in children: single centre experience. Indian J Hematol Blood Transfus (2013) 0.75
Consequences of hemolytic uremic syndrome among hemodialysis patients. J Nephrol (2014) 0.75
Hemolytic uremic syndrome: toxins, vessels, and inflammation. Front Med (Lausanne) (2014) 0.75
Overcoming technical challenges when treating atypical hemolytic uremic syndrome with therapeutic plasma exchange. Int J Nephrol Renovasc Dis (2013) 0.75
End-stage renal disease from hemolytic uremic syndrome in the United States, 1995-2010. Hemodial Int (2015) 0.75
Increased Risk of Acute Kidney Injury following Pneumococcal Pneumonia: A Nationwide Cohort Study. PLoS One (2016) 0.75
Atypical Hemolytic Uremic Syndrome: A Brief Review. Hematol Rep (2017) 0.75
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica (2004) 5.21
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2015) 4.85
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (2011) 4.80
Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA (2007) 4.44
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature (2012) 4.26
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med (2010) 3.86
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia (2006) 3.69
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood (2008) 3.10
Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med (2006) 2.88
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood (2005) 2.45
Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int (2011) 2.43
Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res (2006) 2.42
Is retroperitoneoscopy the gold standard for endoscopic nephrectomy in children on peritoneal dialysis? J Urol (2010) 2.32
Idiopathic mid-aortic syndrome in children. Pediatr Nephrol (2008) 2.14
Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol (2006) 2.09
A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics (2008) 2.08
Enhancing their likelihood for a positive future: the perspective of inner-city youth. Pediatrics (2002) 2.06
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA (2003) 2.04
Performance-based measures of everyday function in mild cognitive impairment. Am J Psychiatry (2010) 1.96
Management of childhood onset nephrotic syndrome. Pediatrics (2009) 1.87
Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol (2007) 1.86
Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. J Am Soc Nephrol (2005) 1.80
Recurrent focal segmental glomerulosclerosis after kidney transplantation. Pediatr Nephrol (2015) 1.73
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia (2013) 1.69
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Critical and honest conversations: the evidence behind the "Choosing Wisely" campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol (2012) 1.69
Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome. J Am Soc Nephrol (2002) 1.63
Substantial practice variation exists in the management of childhood nephrotic syndrome. Pediatr Nephrol (2013) 1.62
Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Curr Opin Pediatr (2013) 1.58
Screening for risk of persistent posttraumatic stress in injured children and their parents. JAMA (2003) 1.56
Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev (2004) 1.55
Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology (2013) 1.52
Defects in the IFT-B component IFT172 cause Jeune and Mainzer-Saldino syndromes in humans. Am J Hum Genet (2013) 1.51
Treatment of posttraumatic stress symptoms in adolescent survivors of childhood cancer and their families: a randomized clinical trial. J Fam Psychol (2004) 1.49
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia (2012) 1.49
The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle Nerve (2013) 1.48
Semantic distance abnormalities in mild cognitive impairment: their nature and relationship to function. Am J Psychiatry (2012) 1.43
Multiple courses of antenatal corticosteroids are associated with early severe lung disease in preterm neonates. J Perinatol (2002) 1.41
Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood (2003) 1.40
A response to "Children in clinical research: a conflict of moral values" by Vera Hassner Sharav. Am J Bioeth (2003) 1.39
U.S. Preventive Services Task Force recommendation and pediatric hypertension screening: dereliction of duty or call to arms? J Clin Hypertens (Greenwich) (2014) 1.38
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int (2010) 1.38
NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol (2007) 1.36
Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol (2009) 1.36
Acute stress disorder symptoms in children and their parents after pediatric traffic injury. Pediatrics (2002) 1.29
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis (2013) 1.29
Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res (2005) 1.23
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics (2005) 1.22
One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial. J Pediatr (2008) 1.21
Reading level of Medicaid renewal applications. Acad Pediatr (2012) 1.20
Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol (2009) 1.16
Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol (2007) 1.16
Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome. Neurology (2013) 1.15
Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol (2002) 1.14
Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res (2004) 1.12
Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol (2004) 1.11
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2006) 1.11
Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2002) 1.10
Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol (2007) 1.09
Treatment of recurrent focal segmental glomerular sclerosis posttransplant with a multimodal approach including high-galactose diet and oral galactose supplementation. Transplantation (2011) 1.08
Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Invest Ophthalmol Vis Sci (2014) 1.07
Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat (2011) 1.06
Assessing health status and health care utilization in adolescents with chronic kidney disease. J Am Soc Nephrol (2005) 1.05
Biomarkers of therapeutic response in primary nephrotic syndrome. Pediatr Nephrol (2012) 1.05
NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol (2008) 1.04
Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. AIDS Res Hum Retroviruses (2008) 1.04
Clinical spectrum of gross hematuria in pediatric patients. Clin Pediatr (Phila) (2006) 1.04
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. Am J Kidney Dis (2009) 1.03
Management of hemolytic uremic syndrome. Presse Med (2012) 1.02
Analysis of genes encoding laminin beta2 and related proteins in patients with Galloway-Mowat syndrome. Pediatr Nephrol (2008) 1.02
Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States. Kidney Int (2013) 1.02
ARHGDIA: a novel gene implicated in nephrotic syndrome. J Med Genet (2013) 1.01
Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study. Ann Neurol (2015) 1.01
The thrombotic microangiopathies. Pediatr Nephrol (2007) 1.01
Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia (2005) 1.00
Accounting for multiple births in neonatal and perinatal trials: systematic review and case study. J Pediatr (2009) 1.00
Cutting balloon angioplasty in children with resistant renal artery stenosis. J Vasc Interv Radiol (2007) 1.00
Patterns of posttraumatic stress symptoms in parents of childhood cancer survivors. J Fam Psychol (2005) 0.99
Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects. Pediatr Nephrol (2012) 0.99
An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol (2014) 0.99
Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol (2005) 0.99
Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a children's oncology group study. Cancer Epidemiol Biomarkers Prev (2006) 0.98
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol (2008) 0.97
Renal manifestations of a mutation in the uromodulin (Tamm Horsfall protein) gene. Am J Kidney Dis (2003) 0.95
Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics (2008) 0.95
Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury. Am J Physiol Renal Physiol (2013) 0.95
CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia. Br J Haematol (2003) 0.95
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients. Adv Chronic Kidney Dis (2011) 0.94
Novel inborn error of folate metabolism: identification by exome capture and sequencing of mutations in the MTHFD1 gene in a single proband. J Med Genet (2011) 0.94
Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol (2013) 0.93
Special education services and school performance in a regional cohort of low-birthweight infants at age nine. Paediatr Perinat Epidemiol (2004) 0.93